CURRENT AFFAIRS

Researchers from Punjabi University, Patiala and PGIMER Chandigarh have developed AI-based diagnostic tools for identifying Autoimmune Blistering Diseases (AIBDs).

Recently, the Union Minister for Science & Technology dedicated the UMMID Programme, a national initiative aimed at improving healthcare services for individuals and families affected by inherited and rare genetic disorders.

The World Health Organization (WHO) recently declared the Ebola outbreak in Democratic Republic of Congo (DRC) and Uganda a Public Health Emergency of International Concern (PHEIC). Global Health Governance.

Recently, India approved 43 new medical colleges along with 20,649 additional MBBS and postgraduate (PG) seats for the academic year 2025–26.

The 'Household Social Consumption: Health' report, recently released by the National Statistical Office (NSO), presents a worrying picture of health in India.

The Union Minister of State for Health and Family Welfare recently informed the Rajya Sabha about the implementation and progress of the National Leprosy Eradication Programme (NLEP), India’s flagship initiative aimed at eliminating leprosy through early detection, treatment, and rehabilitation.

Recent analysis from the Global Burden of Disease Study revealed that India and China have the highest burden of metabolic diseases in the Asia-Pacific region. In India, in particular, the incidence of diabetes, hypertension, obesity, and cholesterol-related diseases is rapidly increasing, posing a serious public health challenge.

A new biosurfactant has been synthesized by an institute under India’s Department of Science and Technology (DST) in Northeast India. This compound has shown effectiveness against Staphylococcus aureus.

Researchers have recently made significant progress toward developing a vaccine against the Epstein–Barr Virus (EBV). This virus infects nearly 95% of the world’s population at some point in life and has been linked to several serious diseases.

The Union government is preparing to launch a nationwide 90-day single-dose HPV vaccination campaign targeting 14-year-old girls to reduce the burden of cervical cancer in India. The initiative marks a major preventive public health intervention aimed at tackling one of the leading causes of cancer-related deaths among Indian women.